NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Sprinklr, Inc. ("Sprinklr" or the "Company") (NYSE:CXM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include […]
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Extreme Networks, Inc. ("Extreme" or the "Company") (NASDAQ:EXTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Stellantis N.V. ("Stellantis" or the "Company") (NYSE:STLA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Terran Orbital Corporation ("Terran" or the "Company") (NYSE:LLAP) and certain officers. The class action, filed in the United States District Court for the Southern District Of Florida, and docketed under 24-cv-81191 is on
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Verve Therapeutics, Inc. ("Verve" or the "Company") (NASDAQ:VERV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Domino’s Pizza, Inc. ("Domino’s" or the "Company") (NYSE:DPZ) and certain officers. The class action, filed in the United States District Court for the Eastern District of Michigan, and docketed under 24-cv-12477, is on
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Agenus Inc. ("Agenus" or the "Company") (NASDAQ:AGEN) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 24-cv-12299, is on behalf of
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ:SAGE) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-06511, is
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ:ARDX) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 24-cv-12119, is on behalf of
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE:ELAN) and certain officers. The class action, filed in the United States District Court for the District Of Maryland, and docketed under 24-cv-02912 is on